# Cerebral Amyloid Imaging Using Florbetapir (AV-45)

> **NCT02813434** · PHASE3 · UNKNOWN · sponsor: **Centre Hospitalier Universitaire, Amiens** · enrollment: 100 (estimated)

## Conditions studied

- Dementia
- Cognition Disorders

## Interventions

- **BIOLOGICAL:** florbetapir

## Key facts

- **NCT ID:** NCT02813434
- **Lead sponsor:** Centre Hospitalier Universitaire, Amiens
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-09
- **Primary completion:** 2022-09
- **Final completion:** 2022-09
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2018-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02813434

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02813434, "Cerebral Amyloid Imaging Using Florbetapir (AV-45)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02813434. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*